Skip to main content

Acucela DRC A Phase 2a Multicenter, Randomized, Masked Study Evaluating the Pharmacodynamics of Emixustat Hydrochloride in Subjects with Macular Atrophy Secondary to Stargardt Disease

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

Acucela Inc.

Start Date

December 6, 2016

End Date

May 9, 2018
 

Administered By

Ophthalmology

Awarded By

Acucela Inc.

Start Date

December 6, 2016

End Date

May 9, 2018